Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis

Internal Medicine Journal

Volumn 32, Issue 3, 2002, Pages 84-88

  Heaton, D C ^a   Han, D Y ^b   Inder, Alison ^b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b NONE   (New Zealand)

Author keywords

Central venous catheters; Thrombosis; Warfarin

Indexed keywords

WARFARIN;

ADULT; ARTICLE; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEMATOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; THROMBOSIS PREVENTION; TREATMENT OUTCOME; VEIN THROMBOSIS;

ADULT; AGED; ANTICOAGULANTS; CATHETERIZATION, CENTRAL VENOUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIMARY PREVENTION; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; THROMBOSIS; TREATMENT OUTCOME; WARFARIN;

EID: 0036379760     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-5994.2002.00171.x     Document Type: Article

References (18)

1. Haire WD, Lieberman RP, Lundi GB, Edney JA, Kessinger A, Armitage JO. Thrombotic complications of silicone rubber catheters during autologous marrow and peripheral stem cell transplantation: prospective comparison of Hickman and Groshong catheters. Bone Marrow Transplant 1991; 7: 57-9.
2. Eastridge BJ, Lefor AT. Complications of indwelling venous access devices in cancer patients. J Clin Oncol 1995; 13: 233-8.
3. Gould JR, Carloss HW, Skinner WL. Groshong catheter-associated subclavian venous thrombosis. Am J Med 1993; 95: 419-23.
4. Craft PS, May J, Dorigo A, Hoy C, Plant A. Hickman catheters: left-sided insertion, male gender, and obesity are associated with an increased risk of complications. Aust NZ J Med 1996; 26: 33-9.
5. Henriques HF, Karmy-Jones R, Knoll SM, Copes WS, Giordano JM. Avoiding complications of long-term venous access. Am Surg 1993; 59: 555-8.
6. Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994; 271: 1014-16.
7. Ruggeri M, Castaman G, Tosetto A, Rodeghiero F. Low prevalence of thrombophilic coagulation defects in patients with deep vein thrombosis of the upper limbs. Blood Coagul Fibrinolysis 1997; 8: 191-4.
8. Holm J, Berntorp E, Carlsson R, Erhardt L. Low-dose warfarin decreases coagulability without affecting prothrombin complex activity. J Intern Med 1993; 234: 303-8.
9. Poller L, McKernan A, Thomson JM, Elstein M, Hirsch PJ, Jones JB. Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery. BMJ 1987; 295: 1309-12.
10. Fordyce MJ, Baker AS, Staddon GE. Efficacy of fixed minidose warfarin prophylaxis in total hip replacement. BMJ 1991; 303: 219-20.
11. Levine M, Hirsh J, Gent M et al. Double-blind randomized trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 1994; 343: 886-9.
12. Bern M, Lokich JJ, Wallach SR et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 1990; 112: 423-8.
13. Smith JG, Summerfield GP, Adam A et al. BCSH guidelines on the insertion and management of central venous lines. Br J Haematol 1997; 98: 1041-7.
14. Levine MN. Prevention of thrombotic disorders in cancer patients undergoing chemotherapy. Thromb Haemost 1997; 78: 133-6.
15. Clagett GP, Anderson FA, Geerts W et al. Prevention Venous Thromboembolism. Chest 1998; 114: 531-60S.
16. Boraks P, Seale J, Price J et al. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol 1998; 101: 483-6.
17. Ratcliffe M, Broadfoot C, Davidson M, Kelly KF, Greaves M. Thrombosis, markers of thrombotic risk, indwelling central venous catheters and antithrombotic prophylaxis using low-dose warfarin in subjects with malignant disease. Clin Lab Haematol 1999; 21: 353-7.
18. Kalev M, Day T, Van de Water N, Ockelford P. Screening for a prothrombotic diathesis in patients attending family planning clinics. NZ Med J 1999; 112: 358-61.